Chronic kidney disease represents another expansion opportunity, supported by data demonstrating renal protection independent of glycemic effects [2]
Earlier this week, the company Hims, arguably the best-known source of compounded GLP-1s, announced that it would stop marketing these drugs as part of a truce formed with Novo Nordisk
Loti Labs has a fast shipping schedule to support time-sensitive research
When asked if there were any concerns about young patients starting this medication so early in life and taking it indefinitely, Arslanian said, this is a very good question that is on everyones radar
Supplements such as beta alanine help to reduce lactic acid buildup in the muscles which help to improve exercise duration and strength of the workout
With the GLP-1 gold rush, everyone seems to be throwing their hat in the ring, from direct-to-consumer channels by drugmakers Eli Lilly and Novo Nordisk to digital startups like Ro Body and Fridays even local medspas